Search Results 31-40 of 16820 for Purine

  1. Gout - Doctors and departments - Mayo Clinic

    Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...

  2. A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy - Mayo Clinic

    a purine analog-containing regimen; a bendamustine-containing regimen; an anti-CD20 antibody-containing regimen; a chlorambucil-containing regimen; an ...

  3. Consumer health - Mayo Clinic

    Take charge of your health. Know your options. Use medicines and supplements wisely. Be informed and ask questions of your health care professionals.

  4. Drugs and Supplements that Start with P - Mayo Clinic

    Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “P” to learn about drug side effects, proper use and ...

  5. irritable bowel syndrome Archives - Mayo Clinic News Network

    and gut microbiota, we identified purine metabolism as a novel metabolic pathway in IBS with contribution from both host and gut microbiota,” says author ...

  6. A Study Of Pirtobrutinib And Brexucabtagene Autoleucel In Relapsed Or Refractory Mantle Cell Lymphoma - Mayo Clinic

    Bendamustine or other purine analogues: 3 months. Corticosteroids: 5 days. The effects of Pirtobrutinib on the developing human fetus are unknown. For this ...

  7. A Study of the Safety and Effectiveness of Using Human Myeloid Progenitor Cells (CLT-008) During Chemotherapy for Acute Myeloid Leukemia - Mayo Clinic

    ... purine nucleoside inhibitors, etoposide, etc.) Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 at Screening or by the day chemotherapy ...

  8. A Study To Evaluate The Safety And Effectiveness Of APT-1011 To Treat Eosinophilic Esophagitis - Mayo Clinic

    Use of calcineurin inhibitors or purine analogues (azathioprine, 6-mercaptopurine) in the 12 weeks before Screening; Use of potent cytochrome P450 (CYP) 3A4 ...

  9. https://www.mayoclinic.org/arabic_procedure_concepts.xml

  10. Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE) - Mayo Clinic

    Use of calcineurin inhibitors or purine analogues, or potent cytochrome P450 (CYP) 3A4 inhibitors in the 12 weeks prior to Screening;; Have a ...